Tricoci, P., D’Andrea, D. M., Gurbel, P., Cuchel, M., Winstons, B., Schott, R., … Alexander, J. H. (2013). Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study. CIRCULATION, 128(22).

Tricoci, Pierluigi, Denise M. D’Andrea, Paul Gurbel, Marina Cuchel, Brion Winstons, Robert Schott, Robert Weiss, et al. “Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study.” CIRCULATION 128, no. 22 (November 26, 2013).

Tricoci P, D’Andrea DM, Gurbel P, Cuchel M, Winstons B, Schott R, et al. Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study. CIRCULATION. 2013 Nov 26;128(22).

Tricoci, Pierluigi, et al. “Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study.” CIRCULATION, vol. 128, no. 22, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2013.

Tricoci P, D’Andrea DM, Gurbel P, Cuchel M, Winstons B, Schott R, Weiss R, Blazing M, Corteville D, Bailey A, Angiolillo DJ, Dalitz P, Myles-Di Mauro S, Shear C, Alexander JH. Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2013 Nov 26;128(22).